background image

S&P 500: 2024 Stars, Flops, and What's Hot for 2025!

As 2024 ends, US equities have had a stellar year, with the S&P 500 delivering a 24% return in USD terms. Diving deeper into the index, the biggest winners and losers tell a story of significant market trends and investment themes that will likely remain relevant into 2025.

Top Performers of 2024

  • Artificial Intelligence Leads the Charge: AI continues to dominate as one of the most significant investment themes, propelling stocks like NVIDIA and Palantir to the top.
    • NVIDIA: Built on its 2023 gains, fueled by unprecedented demand for AI chips.
    • Palantir: Benefited from its enterprise AI solutions, filling unique technology niches.
    • Broadcom: Benefited from expectations of robust AI revenue growth given its differentiated chip design capabilities for high-performance networking and computing that is making it take market share from Nvidia.
  • Energy and Utilities Shine: The push for renewable energy and nuclear power has created immense value in the utility sector.
    • Vistra: Thrived on strong cash flow and renewable energy investments.
    • GE Vernova: Benefited from the renewed focus on nuclear energy as part of the clean energy transition.
  • Defense and Security Make a Comeback: Geopolitical tensions and rising defense budgets boosted stocks in the defense sector.
    • Axon Enterprise: Leveraged higher demand for public safety technology, including TASERs and body cameras.
    • Howmet Aerospace: Played a pivotal role in supplying critical components for military aircraft.
  • Oil and Gas Expansion: Traditional energy had a resurgence, especially in regions like the Permian Basin.
    • Targa Resources and Texas Pacific Land: Both saw strong growth from expanding oil and gas production under the “drill baby drill” narrative.
23_CHCA_Top
Source: Bloomberg, Saxo

Worst Performers of 2024

Not all sectors participated in the rally, as challenges in healthcare, retail, and semiconductors weighed on several stocks.

  • Healthcare Sector Struggles: The healthcare industry faced significant headwinds, with regulatory changes and shifting market dynamics impacting major players.
    • Walgreens Boots Alliance: Struggled with declining foot traffic and increased competition from online pharmacies, leading to a substantial drop in stock value.
    • Moderna: Faced challenges in sustaining growth after the initial success of its COVID-19 vaccines, leading to a significant stock decrease.
    • CVS Health: Faced challenges in adapting to new healthcare models and competitive pressures, resulting in a notable decline in its stock performance.
    • Humana: Experienced a downturn due to increased competition and regulatory uncertainties affecting its healthcare services.
  • Retail Sector Challenges: Economic uncertainties and changing consumer behaviors have taken a toll on retail giants.
    • Dollar Tree: Encountered difficulties in maintaining profitability amidst rising operational costs and shifting consumer preferences.
    • Dollar General: Suffered from economic pressures and a decrease in consumer spending, leading to a significant drop in stock value.
    • Estee Lauder Companies: Faced supply chain disruptions and changing consumer habits, impacting its stock performance negatively.
  • Technology Competition: Some tech firms like Intel struggled to maintain momentum post-pandemic due to the technological shifts in the semiconductor industry, resulting in a steep decline.
  • Energy Transition: High interest rates continued to make the operating environment difficult for renewable energy companies like Enphase Energy.
  • Broader Economic Slowdown: Weakness in auto and industrial sector demand weighed on Celanese.
23_CHCA_Bottom
Source: Bloomberg, Saxo

Investment Themes and Takeaways for 2025

  1. AI Remains a Megatrend: The AI boom is far from over. High valuations in NVIDIA and Palantir reflect investor expectations for sustained growth.
    1. Subthemes such as increased energy needs for data centers will drive opportunities in utilities and clean energy.
    2. NVIDIA thrived due to AI-driven demand, while Intel (-62%) struggled amid reduced consumer electronics sales and competition from companies like Apple making their own chips. This divergence reflects the “elimination race” in the semiconductor space.
  2. Clean Energy & Utilities Are Crucial: The transition to renewables and nuclear energy continues to drive significant returns.
    1. Companies like Vistra and GE Vernova highlight a derived sub-theme—AI’s energy-intensive infrastructure is boosting utilities, particularly those invested in nuclear power.
  3. Defense Spending on the Rise: Global geopolitical tensions make defense and security a critical investment area.
  4. Energy Expansion Is Back: Traditional energy remains vital, with oil and gas companies capitalizing on expanded production opportunities. The “drill baby drill” narrative and US energy independence push suggest ongoing opportunities in traditional energy.
  5. Healthcare May Be Poised for Recovery: Despite current pressures from rising costs and regulatory risks, healthcare remains ripe for growth through defensive strategies and innovations in AI, obesity, and cancer therapies, offering long-term investment opportunities.
  6. Consumer Sector Divergence: The US consumer market is experiencing a shift, with trading down trends becoming more prevalent. This divergence in retail trends presents both challenges and opportunities, as some retailers adapt to changing consumer preferences while others struggle to maintain market share.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.